NCT01082653View on ClinicalTrials.gov

Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis

PHASE1SuspendedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Amyotrophic Lateral Sclerosis
Interventions
BIOLOGICAL

autologous bone marrow-derived stem cells

All patients will receive a unique one-time intrathecal infusion of the cell product suspended in infusion medium.

Trial Locations (1)

70433

TCA Cellular Therapy, Covington

Sponsors
All Listed Sponsors
lead

TCA Cellular Therapy

INDUSTRY